Last reviewed · How we verify
NCT03410498
The Effects of FES in a Variety of Walking Conditions in People With MS
NA trial testing Incremental shuttle walk test in Multiple Sclerosis in 20 participants. Status unknown.
29 December 2024
Quick facts
| Lead sponsor | Queen Margaret University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 20 |
| Start date | 1 August 2018 |
| Primary completion | 29 December 2024 |
| Estimated completion | 29 December 2024 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Incremental shuttle walk test
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
Sponsor
Queen Margaret University
Who can join
Adults 18 to 80, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to measure the difference in the walking performance when functional electrical stimulation (FES) is on and off in people with MS that present foot drop under different 'real life' conditions, i.e. walking while doing another task that requires your attention and after been physically tired
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03410498
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Incremental shuttle walk test
Trials testing the same drug.
- NCT06634238 — Acute Mask Effects on Walk Distance and Vital Signs · not yet recruiting
- NCT04864132 — The Investigation Of Exercise Capacity And Exercise-Induced Fatigue in Young Adults Who Survived From Coronavirus · completed
- NCT04086953 — Validation of a Walk-Time Limit Test (WTLT) Derived from the 6-Minute Walk Test (6-MWT) in Patients with Chronic Cardiov · NA · terminated
- NCT04440124 — Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Undergoing E · completed
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Queen Margaret University trials
Trials by the same sponsor.
- NCT06911151 — Innovative Shoe for People With Foot Drop · NA · not yet recruiting
- NCT06046846 — Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer · NA · unknown
- NCT05453656 — Development and Testing of the Kidney BEAM-KIDS Digital Platform for Children After Kidney Transplantation · NA · unknown
- NCT05137691 — Health After Birth Intervention Trial · NA · terminated
- NCT05234879 — The Feasibility of Frame Running as an Exercise Option for People With Multiple Sclerosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03410498 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Queen Margaret University
- Last refreshed: 18 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03410498.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing